PATENT CLAIM ANALYSIS

Application Number: 16454831
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["514", "210200"]

Abstract:
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.

Claim (Index 1):
A pharmaceutical composition comprising the compound (R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 100.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14589205', '14591372', '15767385', '14005568', '15860379']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7079087204593645
- 35 USC 102 Novelty (BERT): 0.500387042521562
- Combined Prediction Score: 0.6871565526655842
- Mean Citation Score: 204.769912
- Max Citation Score: 263.76288
- Similarity Product: 225.6496738429641

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test